We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 41-60 of 10,000 results
  1. Tumor attachment to Major intrahepatic vascular for Colorectal liver metastases

    Background

    Colorectal liver metastases attached major intrahepatic vessels has been considered to be a risk factor for survival outcome after liver...

    Wei Liu, Yong Cui, ... Bao-Cai **ng in BMC Surgery
    Article Open access 23 June 2023
  2. Transarterial chemoembolization for liver metastases of a pancreatic neuroendocrine neoplasm: a single-center experience

    Transarterial chemoembolization (TACE) is performed for pancreatic neuroendocrine tumor (PanNEN) liver metastases; however, the safety and efficacy...

    Yoshihide Nanno, Hirochika Toyama, ... Takumi Fukumoto in Surgery Today
    Article 24 June 2023
  3. Long-term survival after multidisciplinary treatments for HER2-positive advanced gastric cancer with multiple liver and lung metastases

    Background

    Trastuzumab-based chemotherapy is a standard treatment regimen for human epithelial growth factor 2 (HER2)-positive gastric cancer. This is...

    Satoshi Yoshioka, Naoto Takahashi, ... Ken Eto in Surgical Case Reports
    Article Open access 07 August 2023
  4. SOULMATE: the Swedish study of liver transplantation for isolated colorectal cancer liver metastases not suitable for operation or ablation, compared to best established treatment—a randomized controlled multicenter trial

    Background

    Around one fourth of patients with colorectal cancer present themselves with distant metastases at the time of diagnosis, and one...

    Veronica Reivell, Helga Hagman, ... Helena Taflin in Trials
    Article Open access 30 September 2022
  5. Laparoscopic versus open parenchymal sparing liver resections for high tumour burden colorectal liver metastases: a propensity score matched analysis

    Background

    Laparoscopic liver resection (LLR) has proved effective in the treatment of oligometastatic disease (1 or 2 colorectal liver metastases...

    Nadia Russolillo, Cristina Ciulli, ... Alessandro Ferrero in Surgical Endoscopy
    Article 12 April 2024
  6. Real-world effectiveness and safety of stereotactic body radiotherapy for liver metastases with different respiratory motion management techniques

    Purpose

    Stereotactic body radiotherapy (SBRT) has been firmly established as a treatment choice for patients with oligometastases, as it has...

    O. Hernando-Requejo, X. Chen, ... C. Rubio in Strahlentherapie und Onkologie
    Article 20 September 2023
  7. Repeat hepatectomy for massive liver metastases from pheochromocytoma: a case report

    In malignant pheochromocytoma, the survival benefit of metastasectomy remains unclear. However, excessive catecholamines secreted from...

    Toshihiro Nakayama, Kyoji Ito, ... Norihiro Kokudo in Clinical Journal of Gastroenterology
    Article 21 March 2023
  8. Irinotecan eluting beads-transarterial chemoembolization using Callispheres® microspheres is an effective and safe approach in treating unresectable colorectal cancer liver metastases

    Background

    Callispheres® microspheres (CSM) are the first drug-eluting bead (DEB) product developed in China; meanwhile, DEB-transarterial...

    Guangsheng Zhao, Song Liu, ... Jun Zhou in Irish Journal of Medical Science (1971 -)
    Article Open access 15 July 2021
  9. Perioperative Chemotherapy is Associated with Superior Overall Survival in Patients with Synchronous Colorectal Liver Metastases

    Background

    The sequence of localized and systemic treatment for colorectal liver metastases (CRLM) remains debated. Our objective is to analyze the...

    Joy Sarkar, Kristopher Attwood, Roderich E. Schwarz in Annals of Surgical Oncology
    Article 29 September 2023
  10. Long-term survival after hepatic resection for colorectal liver metastases: a single-center study in Iran

    Background

    Surgical resection of colorectal cancer liver metastasis (CRLM) has been associated with improved survival in these patients. The purpose...

    Seyed Morteza Pourfaraji, Mehdi Nazari Moghadam, ... Ali Jafarian in BMC Surgery
    Article Open access 03 May 2024
  11. Anti-PD-1 antibody in combination with radiotherapy as first-line therapy for unresectable intrahepatic cholangiocarcinoma

    Background

    Unresectable intrahepatic cholangiocarcinoma (iCCA) has a poor prognosis despite treatment with standard combination chemotherapy. We aimed...

    Meiyan Zhu, Meng **, ... Zhenwei Peng in BMC Medicine
    Article Open access 19 April 2024
  12. CT versus MR guidance for radiofrequency ablation in patients with colorectal liver metastases: a 10-year follow-up favors MR guidance

    Objectives

    To compare the results of CT- vs MR-guided radiofrequency ablation (RFA) of liver metastases (LM) from colorectal cancer after 10 years of...

    Philippe Lucien Pereira, Panagiota Siemou, ... Thomas Helmberger in European Radiology
    Article 02 December 2023
  13. The Current State of Liver Transplantation for Colorectal Liver Metastases in the United States: A Call for Standardized Reporting

    Background

    Current success in transplant oncology for select liver tumors, such as hepatocellular carcinoma, has ignited international interest in...

    Kazunari Sasaki, Luis I. Ruffolo, ... Roberto Hernandez-Alejandro in Annals of Surgical Oncology
    Article 31 January 2023
  14. Local Therapy Improves Survival for Early Recurrence After Resection of Colorectal Liver Metastases

    Background

    Early recurrence following hepatectomy for colorectal liver metastases (CLM) is associated with worse survival; yet, impact of further...

    Artem Boyev, Ching-Wei D. Tzeng, ... Timothy E. Newhook in Annals of Surgical Oncology
    Article 27 December 2023
  15. Application of associating liver partition and portal vein ligation for staged hepatectomy for initially unresectable hepatocellular carcinoma

    Objective

    To evaluate the safety and efficacy of associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) in the treatment...

    Haoqi Chen, **aowen Wang, ... Genshu Wang in BMC Surgery
    Article Open access 24 November 2022
  16. Evidence on percutaneous radiofrequency and microwave ablation for liver metastases over the last decade

    Purpose

    This review aimed to summarize the treatment outcomes of percutaneous radiofrequency ablation (RFA) and microwave ablation (MWA) for...

    Koji Tomita, Yusuke Matsui, ... Takao Hiraki in Japanese Journal of Radiology
    Article Open access 13 September 2022
  17. Perioperative safety, oncologic outcome, and risk factors of salvage liver resection for initially unresectable hepatocellular carcinoma converted by transarterial chemoembolization plus tyrosine kinase inhibitor and anti-PD-1 antibody: a retrospective multicenter study of 83 patients

    Background

    To assess the perioperative safety, oncological outcomes, and determinants influencing the oncological outcomes of salvage liver resection...

    Kong-Ying Lin, Zhi-Wen Lin, ... Yong-Yi Zeng in Hepatology International
    Article 29 June 2023
  18. Thermal ablation versus hepatic resection for colorectal cancer with synchronous liver metastases: a propensity score matching study

    Objectives

    Several studies have compared the efficacy of hepatic resection (HR) and thermal ablation (TA) for unresectable tumors; however, results...

    Yun Xu, Yuqin Zhang, ... Ye Xu in European Radiology
    Article 24 August 2022
  19. Quality of Life Analysis of Patients Treated with Percutaneous Hepatic Perfusion for Uveal Melanoma Liver Metastases

    Purpose

    Percutaneous hepatic perfusion with melphalan (M-PHP) is a minimally invasive therapy with proven efficacy in patients with uveal melanoma...

    T. M. L. Tong, M. Fiocco, ... M. C. Burgmans in CardioVascular and Interventional Radiology
    Article Open access 08 April 2024
Did you find what you were looking for? Share feedback.